Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05269316
Title Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Impact Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Hackensack University Medical Center PARTNER COMPLETED Hackensack New Jersey 07601 United States Details
Mount Sinai COMPLETED New York New York 10029 United States Details
Greenville Hospital System University Medical Center (ITOR) COMPLETED Greenville South Carolina 29605 United States Details
Mary Crowley Cancer Research Centers COMPLETED Dallas Texas 75251 United States Details
Blacktown Hospital COMPLETED Blacktown New South Wales 2148 Australia Details
Linear Clinical Research Limited COMPLETED Nedlands 6009 Australia Details
Beijing Cancer Hospital RECRUITING Beijing Beijing 100142 China Details
National Taiwan University Hospital RECRUITING Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field